DOCSLIB.ORG

Economy Assessment for the Chiral Amine Production with Comparison of Reductive Amination and Transamination Routes by Multi-Enzyme System

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Economy Assessment for the Chiral Amine Production with Comparison of Reductive Amination and Transamination Routes by Multi-Enzyme System catalysts Article Economy Assessment for the Chiral Amine Production with Comparison of Reductive Amination and Transamination Routes by Multi-Enzyme System Heyu Huo 1, Guangxiao Yao 1 and Shizhen Wang 1,2,* 1 Department of Chemical and Biochemical Engineering, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China; [email protected] (H.H.); [email protected] (G.Y.) 2 The Key Lab for Synthetic Biotechnology of Xiamen City, Xiamen University, Xiamen 361005, China * Correspondence: [email protected]; Tel.: +86-592-218-3751 Received: 22 October 2020; Accepted: 6 December 2020; Published: 11 December 2020 Abstract: Chiral amines are key building blocks for pharmaceuticals. Economic assessment of commercial potential of bioprocesses is needed for guiding research. Biosynthesis of (S)-α-methylbenzylamine (MBA) was selected as case study. For transamination route, transaminase coupled with glucose dehydrogenase and lactate dehydrogenase catalyzed the reaction with NADH (Nicotinamide adenine dinucleotide) regeneration. Amine dehydrogenase coupled with NADH oxidase, which catalyzed the reductive amination process. Comparison of biosynthesis cost by reductive amination and transamination routes was carried out. Economic assessment based on the framework of cost analysis and preliminary process information revealed that cost is greatly dependent on enzyme price. The results indicated that enhancing the activity of amine dehydrogenase by 4–5 folds can drop the unit price of reductive amination to $0.5–0.6/g, which make it competitive with transamination route. Keywords: chiral amine; amine dehydrogenase; transaminase; multi-enzyme system; economic estimation; bioprocess 1. Introduction Chiral amines are key building blocks for many new pharmaceutical products. Transaminases have emerged as an attractive alternative for chiral amine synthesis, due to their high enantioselectivity. However, there are still many challenges that need to be overcome to make the technology more widely applicable such as unfavorable equilibrium, low substrate solubility, low activity, low stability of the biocatalyst as well as product, and substrate inhibition [1]. The success of a biocatalytic process ultimately depends on the economic profile of the process. Economic assessment in early-stage can guide research and development activities to achieve commercial potential by identifying process bottlenecks. Once these bottlenecks are identified, prioritizing research and development (R&D) efforts to overcome these barriers has the greatest impact on the process. Therefore, such an evaluation can guarantee efficient utilization of limited resources to attain competitiveness in an industrial environment [2]. However, compared with chemical process, the data and modeling for unit operation of biomanufacturing are insufficient. Increasing awareness for economic analysis of biotechnology has a profound and lasting significance for the biomanufacturing development [3]. Application of economic analysis in decision-making in research and design is a key factor to fulfill the economic requirements for commercial operation [4]. This paper demonstrates an approach of economic analysis of biocatalytic processes and illustrates it using a case study. Using the framework of cost analysis and preliminary Catalysts 2020, 10, 1451; doi:10.3390/catal10121451 www.mdpi.com/journal/catalysts Catalysts 2020, 10, 1451 2 of 8 processCatalysts information, 2020, 10, x FOR economicPEER REVIEW assessments of two multi-enzyme system for chiral amine production2 of 9 were studied, namely, transamination process and reductive amination by transaminase and amine dehydrogenasestudied, namely, system, transamination respectively process [5]. Amine and dehydrogenasesreductive amination dependent by transaminase on NADH canand catalyzeamine thedehydrogenase direct reductive system, amination respectively of ketones[5]. Amine with dehydrogenases high enantioselectivity. dependent Asymmetric on NADH can synthesis catalyze of the direct reductive amination of ketones with high enantioselectivity. Asymmetric synthesis of chiral chiral amines by amine dehydrogenases is an ideal route for chiral amines production coupled with a amines by amine dehydrogenases is an ideal route for chiral amines production coupled with a cofactor recycling system with the consumption of an inexpensive agent, such as free ammonia [6]. cofactor recycling system with the consumption of an inexpensive agent, such as free ammonia [6]. Multi-enzyme biosynthesis of chiral amine based on amine dehydrogenases is with the advantages of Multi-enzyme biosynthesis of chiral amine based on amine dehydrogenases is with the advantages simple reaction system and easy co-enzyme regeneration [7,8]. of simple reaction system and easy co-enzyme regeneration [7,8]. 2. Results and Discussion 2. Results and Discussion General assumptions were made as a plant to produce 600 kg (S)-α-methylbenzylamine (MBA) General assumptions were made as a plant to produce 600 kg (S)-α-methylbenzylamine (MBA) (99% ee) per year at concentrations by commercially available transaminases. The plant uses a 2 m3 (99% ee) per year at concentrations by commercially available transaminases. The plant uses a 2 m3 reactor and operates with a 50-h process cycle time. reactor and operates with a 50-h process cycle time. Assume that the equipment cost and waste disposal cost are the same, the reaction time of the Assume that the equipment cost and waste disposal cost are the same, the reaction time of the reductive amination is 48 h, and the reaction time of the transamination is 50 h, which can be roughly reductive amination is 48 h, and the reaction time of the transamination is 50 h, which can be roughly regarded as the same time. Therefore, the difference in total cost lies in the price of raw materials and regarded as the same time. Therefore, the difference in total cost lies in the price of raw materials and the enzyme activity of the reaction. the enzyme activity of the reaction. 2.1. Multi-Enzyme System of Transamination 2.1. Multi-Enzyme System of Transamination Biosynthesis of chiral amines from their corresponding ketones by a multi-enzyme system, Biosynthesis of chiral amines from their corresponding ketones by a multi-enzyme system, which consists of transaminases, glucose dehydrogenase, and lactate dehydrogenase with cofactor which consists of transaminases, glucose dehydrogenase, and lactate dehydrogenase with cofactor regeneration, is selected as a case study (Figure1). The amine donor is alanine. The generated pyruvate regeneration, is selected as a case study (Figure 1). The amine donor is alanine. The generated ispyruvate reduced intois reduced L-lactate into by L-lactate lactate dehydrogenase by lactate dehydrogenase (LDH), which (LDH), eliminates which pyruvate eliminates inhibition pyruvate to theinhibition transaminase to the transaminase and lifts the and reaction lifts the equilibrium. reaction equilibrium. NADH regeneration NADH regeneration is achieved is achieved by glucose by dehydrogenaseglucose dehydrogenase (GDH). Ion-exchange (GDH). Ion-exchange resin is applied resin for is inapplied situ product for in removal.situ product The desiredremoval. product The isdesired separated product with ais moreseparated than with 90% yielda more [5 than]. 90% yield [5]. FigureFigure 1. 1.Multi-enzyme Multi-enzyme catalyzedcatalyzed transamination [5]. [5]. TheThe bioprocess bioprocess shown shown inin FigureFigure2 2is is as as follows: follows: (1)(1) bioconversionbioconversion of the ketone to to amine amine and and cofactorcofactor regeneration, regeneration, (2) (2) separation separation ofof thethe ion-exchangeion-exchange resin resin from from the the reaction reaction mixture mixture by by filtration, filtration, andand (3) (3) isolation isolation and and purification purification of of productproduct amine.amine. Catalysts 2020, 10, 1451 3 of 8 Catalysts 2020, 10, x FOR PEER REVIEW 3 of 9 Figure 2. Overview of the biocatalytic transamination process. Figure 2. Overview of the biocatalytic transamination process. Reaction condition: 100 mM potassium phosphate buffer (pH 7.5), 1 g/L NAD+ (Nicotinamide Reaction condition: 100 mM potassium phosphate buffer (pH 7.5), 1 g/L NAD+ (Nicotinamide adenine dinucleotide), 0.5 g/L pyridoxal-5-phosphate, 90 g/L glucose, 90 g/L alanine, 50 g/L adenine dinucleotide), 0.5 g/L pyridoxal-5-phosphate, 90 g/L glucose, 90 g/L alanine, 50 g/L acetophenone, 1 g/L glucose dehydrogenase (GDH), 1 g/L lactate dehydrogenase (LDH), 5 g/L acetophenone, 1 g/L glucose dehydrogenase (GDH), 1 g/L lactate dehydrogenase (LDH), 5 g/L transaminase (ATA), and 200 g/L ion-exchange resin (Amberlite XAD 1180). Reactions were run at transaminase (ATA), and 200 g/L ion-exchange resin (Amberlite XAD 1180). Reactions were run at 30 ◦C in a Multimax reactor system with overhead mechanical stirring at 400 rpm. 30 °C in a Multimax reactor system with overhead mechanical stirring at 400 rpm. Route cost analysis: Route cost analysis: The cost list of the two synthetic routes is shown in Tables 1–8. See Tables1 and2: The cost list of the two synthetic routes is shown in Tables 1–8: Table 1. Raw material costs per batch of transamination process. Table 1. Raw material costs per batch of transamination process. Concentration Raw Materials Weight (kg/Batch) Unit Price a ($/Kg) Cost ($) Concentration(g/L) Weight Unit Price a Raw Materials Cost ($) Transaminase (ATA-113) 5(g/L) 5(kg/Batch) 50,000($/Kg) 250,000 Lactate
Load more

Recommended publications
  • The Role of Protein Crystallography in Defining the Mechanisms of Biogenesis and Catalysis in Copper Amine Oxidase
    Int. J. Mol. Sci. 2012, 13, 5375-5405; doi:10.3390/ijms13055375 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review The Role of Protein Crystallography in Defining the Mechanisms of Biogenesis and Catalysis in Copper Amine Oxidase Valerie J. Klema and Carrie M. Wilmot * Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 321 Church St. SE, Minneapolis, MN 55455, USA; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-612-624-2406; Fax: +1-612-624-5121. Received: 6 April 2012; in revised form: 22 April 2012 / Accepted: 26 April 2012 / Published: 3 May 2012 Abstract: Copper amine oxidases (CAOs) are a ubiquitous group of enzymes that catalyze the conversion of primary amines to aldehydes coupled to the reduction of O2 to H2O2. These enzymes utilize a wide range of substrates from methylamine to polypeptides. Changes in CAO activity are correlated with a variety of human diseases, including diabetes mellitus, Alzheimer’s disease, and inflammatory disorders. CAOs contain a cofactor, 2,4,5-trihydroxyphenylalanine quinone (TPQ), that is required for catalytic activity and synthesized through the post-translational modification of a tyrosine residue within the CAO polypeptide. TPQ generation is a self-processing event only requiring the addition of oxygen and Cu(II) to the apoCAO. Thus, the CAO active site supports two very different reactions: TPQ synthesis, and the two electron oxidation of primary amines. Crystal structures are available from bacterial through to human sources, and have given insight into substrate preference, stereospecificity, and structural changes during biogenesis and catalysis.
    [Show full text]
  • C1 Assimilation in Obligate Methylotrophs and Restricted Facultative Methylotrophs by JOHN COLBY* and LEONARD J
    Biochem. J. (1975) 148, 513-520 513 Printed in Great Britain Enzymological Aspects ofthe Pathways for Trimethylamine Oxidation and C1 Assimilation in Obligate Methylotrophs and Restricted Facultative Methylotrophs By JOHN COLBY* and LEONARD J. ZATMAN Department ofMicrobiology, University ofReading, Reading RG1 5AQ, U.K. (Received8 January 1975) 1. Extracts of trimethylamine-grown W6A and W3A1 (type M restricted facultative methylotrophs) contain trimethylamine dehydrogenase whereas similar extracts of Bacillus PM6 and Bacillus S2A1 (type L restricted facultative methylotrophs) contain trimethylamine mono-oxygenase and trimethylamine N-oxide demethylase but no trimethylamine dehydrogenase. 2. Extracts oftherestricted facultatives and ofthe obligate methylotroph C2A1 contain hexulose phosphate synthase-hexulose phosphate isomerase activity; hydroxypyruvate reductase was not detected. 3. Neither the restricted facultatives nor the obligates 4B6 and C2A1 contain all the enzymes ofthe hexulose phos- phatecycleofformaldehyde assimilation as originallyproposed byKemp & Quayle (1967). 4. Organisms PM6 and S2A1 lack transaldolase and use a modified cycle involving sedoheptulose 1,7-diphosphate and sedoheptulose diphosphatase. 5. The obligates 4B6 and C2A1, and the type M organisms W6A and W3A1, use a different modification of the assimilatory hexulose phosphate cycle involving the Entner-Doudoroff-pathway enzymes phosphogluconate dehydratase and phospho-2-keto-3-deoxygluconate aldolase. Thelackoffructosediphosphatealdolaseandhexosediphosphataseintheseorganismsmay
    [Show full text]
  • Novel Amine Dehydrogenase from Leucine Dehydrogenase 19
    DEVELOPMENT OF AN AMINE DEHYDROGENASE A Dissertation Presented to The Academic Faculty by Michael J. Abrahamson In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the School of Chemical and Biomolecular Engineering Georgia Institute of Technology December 2012 DEVELOPMENT OF AN AMINE DEHYDROGENASE Approved by: Dr. Andreas S. Bommarius, Advisor Dr. Jeffrey Skolnick School of Chemical & Biomolecular School of Biology Engineering Georgia Institute of Technology Georgia Institute of Technology Dr. Christopher W. Jones Dr. John W. Wong School of Chemical & Biomolecular Biocatalysis Center of Emphasis Engineering Chemical Research & Development Georgia Institute of Technology Pfizer Global Research & Development Dr. Yoshiaki Kawajiri School of Chemical & Biomolecular Engineering Georgia Institute of Technology Date Approved: August 13, 2012 To my parents, Joseph & Deborah ACKNOWLEDGEMENTS First and foremost, I would like to thank my parents Joseph and Deborah. Your guidance and unconditional support has been invaluable to my success throughout college. The encouragement from my entire family has been so helpful throughout graduate school. I would also like to thank my advisor, Prof. Andreas Bommarius for his direction, instruction, and patience over the last five years. Your input and optimism has kept me ‘plowing ahead’ and has been instrumental in my scientific development. I would like to thank my committee members; Prof. Christopher Jones, Prof. Yoshiaki Kawajiri, Prof. Jeffrey Skolnick, and Dr. John W. Wong. Thank you all for your time, encouragement, and support. All of the members of the Bommarius lab, past and present, have made my graduate career not only productive, but enjoyable. We have shared many great and unforgettable moments.
    [Show full text]
  • Glutamate-Secretion-In-Cancer-Cell
    Biochemical and Biophysical Research Communications 495 (2018) 761e767 Contents lists available at ScienceDirect Biochemical and Biophysical Research Communications journal homepage: www.elsevier.com/locate/ybbrc Glutamate production from ammonia via glutamate dehydrogenase 2 activity supports cancer cell proliferation under glutamine depletion * Yukiko Takeuchi a, Yasumune Nakayama b, c, Eiichiro Fukusaki b, Yasuhiro Irino a, d, a The Integrated Center for Mass Spectrometry, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan b Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan c Department of Applied Microbial Technology, Faculty of Biotechnology and Life Science, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan d Division of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan article info abstract Article history: Cancer cells rapidly consume glutamine as a carbon and nitrogen source to support proliferation, but the Received 9 November 2017 cell number continues to increase exponentially after glutamine is nearly depleted from the medium. In Accepted 13 November 2017 contrast, cell proliferation rates are strongly depressed when cells are cultured in glutamine-free me- Available online 14 November 2017 dium. How cancer cells survive in response to nutrient limitation and cellular stress remains poorly understood. In addition, rapid glutamine catabolism yields ammonia, which is a potentially toxic Keywords: metabolite that is secreted into the extracellular space. Here, we show that ammonia can be utilized for Ammonia glutamate production, leading to cell proliferation under glutamine-depleted conditions.
    [Show full text]
  • Identification, Characterization and Site-Saturation Mutagenesis of a Thermostable
    Identication, Characterization and Site-Saturation Mutagenesis of a Thermostable ω-Transaminase From Chloroexi Bacterium Chen Wang Nanjing Tech University Kexin Tang Nanjing Tech University Ya Dai Nanjing Tech University Honghua Jia ( [email protected] ) Nanjing Tech University https://orcid.org/0000-0002-3824-7768 Yan Li Nanjing Tech University Zhen Gao Nanjing Tech University Bin Wu Nanjing Tech University Research Keywords: ω-Transaminase,Chloroexibacterium, Characterization,Substrate specicity, Site- saturationmutagenesis Posted Date: March 17th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-296936/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Identification, characterization and site-saturation mutagenesis of a thermostable ω-transaminase from Chloroflexi bacterium Chen Wang, Kexin Tang, Ya Dai, Honghua Jia*, Yan Li*, Zhen Gao, Bin Wu College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing 211816, China Correspondent authors: [email protected]; [email protected] Abstract In present study, we have mined a ω-transaminase (ω-TA) from Chloroflexi bacterium from genome database by using an ω-TA sequence ATA117 Arrmut11 from Arthrobacter sp. KNK168 and an amine transaminase from Aspergillus terreus as templates in a BLASTP search and motif sequence alignment. The protein sequence of the ω-TA from C. bacterium shows 38% sequence identity to ATA117 Arrmut11. The gene sequence of the ω-TA was inserted into pRSF-Duet1 and functionally expressed in E. coli BL21(DE3). Results showed that the recombinant ω-TA has a specific activity of 1.19 U/mg at pH 8.5, 40 °C. The substrate acceptability test showed that ω-TA has significant reactivity to aromatic amino donors and amino receptors.
    [Show full text]
  • 1 Here Are the Quiz 4 Questions You Will Answer Online Using the Quiz
    Chemistry 6720, quiz 4 handout Here are the quiz 4 questions you will answer online using the quiz tool in canvas instructure. Some of the questions deal with citric acid cycle enzymes that use mechanistic strategies covered in the lectures. Since we did not cover all of those specific enzymes in lecture, be sure to review the citric acid cycle ahead of taking the quiz online so you can answer the appropriate questions regarding mechanistic strategies/themes for the enzymes. In doing so, practice drawing mechanisms for each enzyme of the citric acid cycle. You will probably need to look up the mechanisms for isocitrate dehydrogenase, aconitase, succinate dehydrogenase, and succinyl-CoA synthetase in a general biochemistry text. I will not be asking specific details of the mechanisms for those 4 enzymes, but you will still need to be generally familiar with how they operate to answer a few of the questions below. You do not need to know the chemistry of FAD reduction for the quiz. Be sure to note the quiz deadline in canvas to be sure you get your answers submitted by the deadline. 1. Shown at the right is a Fischer projection for D-glucose. Use the strategy described in the lecture to assign the configurations (R or S) of the chiral centers at C2, C3, C4, and C5. 2. Using the structures shown to the right, assign the methyl groups of isopropanol, and the hydrogens at C2 and C3 of succinate, as either ProR or ProS. Use the strategy covered in lecture to guide you in making the assignments.
    [Show full text]
  • Kobe University Repository : Kernel
    Kobe University Repository : Kernel タイトル Glutamate production from ammonia via glutamate dehydrogenase 2 Title activity supports cancer cell proliferation under glutamine depletion 著者 Takeuchi, Yukiko / Nakayama, Yasumune / Fukusaki, Eiichiro / Irino, Author(s) Yasuhiro 掲載誌・巻号・ページ Biochemical and Biophysical Research Communications,495(1):761- Citation 767 刊行日 2018-01-01 Issue date 資源タイプ Journal Article / 学術雑誌論文 Resource Type 版区分 author Resource Version © 2017 Elsevier. This manuscript version is made available under the 権利 CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc- Rights nd/4.0/ DOI 10.1016/j.bbrc.2017.11.088 JaLCDOI URL http://www.lib.kobe-u.ac.jp/handle_kernel/90005457 PDF issue: 2021-10-11 Glutamate production from ammonia via glutamate dehydrogenase 2 activity supports cancer cell proliferation under glutamine depletion Yukiko Takeuchia, Yasumune Nakayamab, c, Eiichiro Fukusakib and Yasuhiro Irinoa, d aThe Integrated Center for Mass Spectrometry, Kobe University Graduate School of Medicine, 7- 5-1 Kusunoki-cho, Kobe 650-0017, Japan bDepartment of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamada- oka, Suita, Osaka 565-0871, Japan cDepartment of Applied Microbial Technology, Faculty of Biotechnology and Life Science, Sojo University, 4-22-1 Ikeda, Kumamoto 860-0082, Japan dDivision of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Kobe 650-0017, Japan Address for correspondence: Yasuhiro Irino, PhD. Assistant Professor, Division of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan Tel.: +81-78-382-5846; Fax: +81-78-382-5859; E-mail: [email protected] 1 Abstract Cancer cells rapidly consume glutamine as a carbon and nitrogen source to support proliferation, but the cell number continues to increase exponentially after glutamine is nearly depleted from the medium.
    [Show full text]
  • A Family of Native Amine Dehydrogenases for the Asymmetric Reductive Amination of Ketones
    A family of native amine dehydrogenases for the asymmetric reductive amination of ketones Ombeline Mayol, Karine Bastard, Lilian Beloti, Amina Frese, Johan P Turkenburg, Jean-Louis Petit, Aline Mariage, Adrien Debard, Virginie Pellouin, Alain Perret, et al. To cite this version: Ombeline Mayol, Karine Bastard, Lilian Beloti, Amina Frese, Johan P Turkenburg, et al.. A family of native amine dehydrogenases for the asymmetric reductive amination of ketones. Nature Catalysis, Nature Publishing Group, 2019, 2 (4), pp.324-333. 10.1038/s41929-019-0249-z. hal-02945525 HAL Id: hal-02945525 https://hal.archives-ouvertes.fr/hal-02945525 Submitted on 22 Sep 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. A family of Native Amine Dehydrogenases for the Asymmetric Reductive Amination of Ketones Ombeline Mayol1, Karine Bastard1, Lilian Beloti2, Amina Frese2, Johan P. Turkenburg2, Jean-Louis Petit1, Aline Mariage1, Adrien Debard1, Virginie Pellouin1, Alain Perret1, Véronique de Berardinis1, Anne Zaparucha1, Gideon Grogan*2, Carine Vergne-Vaxelaire*1 1 Génomique Métabolique, Genoscope, Institut François Jacob, CEA, CNRS, Univ Evry, Université Paris-Saclay, 91057 Evry, France 2 York Structural Biology Laboratory, Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.
    [Show full text]
  • Distribution of Amine Oxidases and Amine Dehydrogenases in Bacteria Grown on Primary Amines and Characterization of the Amine Oxidase from Klebsiella Oxytoca
    Microbiology (1997), 143, 505–512 Printed in Great Britain Distribution of amine oxidases and amine dehydrogenases in bacteria grown on primary amines and characterization of the amine oxidase from Klebsiella oxytoca Ayse Hacisalihoglu, Jaap A. Jongejan and Johannis A. Duine Author for correspondence: J. A. Duine. Tel: ­31 15 2785051. Fax: ­31 15 2782355. e-mail: J. A. Duine!STM.TUDelft.NL Department of Microbiology The bacteria Klebsiella oxytoca LMD 72.65 (ATCC 8724), Arthrobacter P1 LMD and Enzymology, Delft 81.60 (NCIB 11625), Paracoccus versutus LMD 80.62 (ATCC 25364), Escherichia University of Technology, Julianalaan 67, 2628 BC coli W LMD 50.28 (ATCC 9637), E. coli K12 LMD 93.68, Pseudomonas aeruginosa Delft, The Netherlands PAO1 LMD 89.1 (ATCC 17933) and Pseudomonas putida LMD 68.20 (ATCC 12633) utilized primary amines as a carbon and energy source, although the range of amines accepted varied from organism to organism. The Gram-negative bacteria K. oxytoca and E. coli as well as the Gram-positive methylotroph Arthrobacter P1 used an oxidase whereas the pseudomonads and the Gram- negative methylotroph Paracoccus versutus used a dehydrogenase for amine oxidation. K. oxytoca utilized several primary amines but showed a preference for those containing a phenyl group moiety. Only a single oxidase was used for oxidation of the amines. After purification, the following characteristics of the enzyme indicated that it belonged to the group of copper-quinoprotein amine oxidases (EC 1.4.3.6): the molecular mass (172000 Da) of the homodimeric protein; the UV/visible and EPR spectra of isolated and p- nitrophenylhydrazine-inhibited enzyme; the presence and the content of copper and topaquinone (TPQ).
    [Show full text]
  • Transgenic Expression Ofglud1(Glutamate Dehydrogenase
    The Journal of Neuroscience, November 4, 2009 • 29(44):13929–13944 • 13929 Cellular/Molecular Transgenic Expression of Glud1 (Glutamate Dehydrogenase 1) in Neurons: In Vivo Model of Enhanced Glutamate Release, Altered Synaptic Plasticity, and Selective Neuronal Vulnerability Xiaodong Bao,1,2 Ranu Pal,1,2,3 Kevin N. Hascup,4 Yongfu Wang,5 Wen-Tung Wang,6 Wenhao Xu,8 Dongwei Hui,1 Abdulbaki Agbas,1,2 Xinkun Wang,1,2,3 Mary L. Michaelis,1,2 In-Young Choi,5,6,7 Andrei B. Belousov,5 Greg A. Gerhardt,4 and Elias K. Michaelis1,2,3 1Higuchi Biosciences Center, 2Department of Pharmacology and Toxicology, and 3Life Span Studies Institute, University of Kansas, Lawrence, Kansas 66047, 4Anatomy and Neurobiology, Center for Microelectrode Technology, Morris K. Udall Parkinson’s Disease Research Center of Excellence, University of Kentucky, College of Medicine, Lexington, Kentucky 40536, 5Department of Molecular and Integrative Physiology, 6Hoglund Brain Imaging Center, and 7Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, and 8Department of Microbiology, University of Virginia Health System, Charlottesville, Virginia 22908 The effects of lifelong, moderate excess release of glutamate (Glu) in the CNS have not been previously characterized. We created a transgenic (Tg) mouse model of lifelong excess synaptic Glu release in the CNS by introducing the gene for glutamate dehydrogenase 1 (Glud1) under the control of the neuron-specific enolase promoter. Glud1 is, potentially, an important enzyme in the pathway of Glu synthesis in nerve terminals. Increased levels of GLUD protein and activity in CNS neurons of hemizygous Tg mice were associated with increases in the in vivo release of Glu after neuronal depolarization in striatum and in the frequency and amplitude of miniature EPSCs in the CA1 region of the hippocampus.
    [Show full text]
  • Structure of a Quinohemoprotein Amine Dehydrogenase with an Uncommon Redox Cofactor and Highly Unusual Crosslinking
    Structure of a quinohemoprotein amine dehydrogenase with an uncommon redox cofactor and highly unusual crosslinking Saumen Datta*, Youichi Mori†, Kazuyoshi Takagi‡§, Katsunori Kawaguchi‡, Zhi-Wei Chen*, Toshihide Okajima†, Shun’ichi Kuroda†, Tokuji Ikeda‡, Kenji Kano‡, Katsuyuki Tanizawa†¶, and F. Scott Mathews*¶ʈ *Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110; †Department of Structural Molecular Biology, Institute of Scientific and Industrial Research, Osaka University, Ibaraki, Osaka 567-0047, Japan; and ‡Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan Edited by Perry A. Frey, University of Wisconsin, Madison, WI, and approved October 1, 2001 (received for review August 14, 2001) The crystal structure of the heterotrimeric quinohemoprotein The Gram-negative chemoorganotrophic bacterium Paracoc- amine dehydrogenase from Paracoccus denitrificans has been de- cus denitrificans contains two amine dehydrogenases in its termined at 2.05-Å resolution. Within an 82-residue subunit is periplasm, one being the well-known TTQ-containing MADH contained an unusual redox cofactor, cysteine tryptophylquinone and the other a quinohemoprotein amine dehydrogenase (CTQ), consisting of an orthoquinone-modified tryptophan side (QHNDH) that is preferentially induced by growth on n- chain covalently linked to a nearby cysteine side chain. The subunit butylamine (10). QHNDH was reported to be a heterodimer of is surrounded on three sides by a 489-residue, four-domain subunit 96-kDa molecular mass. The large subunit of 60 kDa appeared that includes a diheme cytochrome c. Both subunits sit on the to contain one heme c per molecule and to stain positively for surface of a third subunit, a 337-residue seven-bladed ␤-propeller quinone-dependent redox cycling.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur Et Al
    US 2012026.6329A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur et al. (43) Pub. Date: Oct. 18, 2012 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/10 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/24 (2006.01) CI2N 9/02 (2006.01) (75) Inventors: Eric J. Mathur, Carlsbad, CA CI2N 9/06 (2006.01) (US); Cathy Chang, San Marcos, CI2P 2L/02 (2006.01) CA (US) CI2O I/04 (2006.01) CI2N 9/96 (2006.01) (73) Assignee: BP Corporation North America CI2N 5/82 (2006.01) Inc., Houston, TX (US) CI2N 15/53 (2006.01) CI2N IS/54 (2006.01) CI2N 15/57 2006.O1 (22) Filed: Feb. 20, 2012 CI2N IS/60 308: Related U.S. Application Data EN f :08: (62) Division of application No. 1 1/817,403, filed on May AOIH 5/00 (2006.01) 7, 2008, now Pat. No. 8,119,385, filed as application AOIH 5/10 (2006.01) No. PCT/US2006/007642 on Mar. 3, 2006. C07K I4/00 (2006.01) CI2N IS/II (2006.01) (60) Provisional application No. 60/658,984, filed on Mar. AOIH I/06 (2006.01) 4, 2005. CI2N 15/63 (2006.01) Publication Classification (52) U.S. Cl. ................... 800/293; 435/320.1; 435/252.3: 435/325; 435/254.11: 435/254.2:435/348; (51) Int. Cl. 435/419; 435/195; 435/196; 435/198: 435/233; CI2N 15/52 (2006.01) 435/201:435/232; 435/208; 435/227; 435/193; CI2N 15/85 (2006.01) 435/200; 435/189: 435/191: 435/69.1; 435/34; CI2N 5/86 (2006.01) 435/188:536/23.2; 435/468; 800/298; 800/320; CI2N 15/867 (2006.01) 800/317.2: 800/317.4: 800/320.3: 800/306; CI2N 5/864 (2006.01) 800/312 800/320.2: 800/317.3; 800/322; CI2N 5/8 (2006.01) 800/320.1; 530/350, 536/23.1: 800/278; 800/294 CI2N I/2 (2006.01) CI2N 5/10 (2006.01) (57) ABSTRACT CI2N L/15 (2006.01) CI2N I/19 (2006.01) The invention provides polypeptides, including enzymes, CI2N 9/14 (2006.01) structural proteins and binding proteins, polynucleotides CI2N 9/16 (2006.01) encoding these polypeptides, and methods of making and CI2N 9/20 (2006.01) using these polynucleotides and polypeptides.
    [Show full text]